Takeda Ordered to Pay $6 Billion in Diabetes-Drug Case

A U.S. jury imposed $6 billion in punitive damages on Takeda Pharmaceutical in a case involving allegations that the company hid the cancer risks of its Actos diabetes drug.

Leave a Reply

Your email address will not be published. Required fields are marked *